| T43201D | Poisoning by unspecified antidepressants, accidental (unintentional), subsequent encounter |
| T43202D | Poisoning by unspecified antidepressants, intentional self-harm, subsequent encounter |
| T43203D | Poisoning by unspecified antidepressants, assault, subsequent encounter |
| T43204D | Poisoning by unspecified antidepressants, undetermined, subsequent encounter |
| T43205D | Adverse effect of unspecified antidepressants, subsequent encounter |
| T43206A | Underdosing of unspecified antidepressants, initial encounter |
| T43206D | Underdosing of unspecified antidepressants, subsequent encounter |
| T43206S | Underdosing of unspecified antidepressants, sequela |
| T43211D | Poisoning by selective serotonin and norepinephrine reuptake inhibitors, accidental (unintentional), subsequent encounter |
| T43212D | Poisoning by selective serotonin and norepinephrine reuptake inhibitors, intentional self-harm, subsequent encounter |
| T43213D | Poisoning by selective serotonin and norepinephrine reuptake inhibitors, assault, subsequent encounter |
| T43214D | Poisoning by selective serotonin and norepinephrine reuptake inhibitors, undetermined, subsequent encounter |
| T43215D | Adverse effect of selective serotonin and norepinephrine reuptake inhibitors, subsequent encounter |
| T43216A | Underdosing of selective serotonin and norepinephrine reuptake inhibitors, initial encounter |
| T43216D | Underdosing of selective serotonin and norepinephrine reuptake inhibitors, subsequent encounter |
| T43216S | Underdosing of selective serotonin and norepinephrine reuptake inhibitors, sequela |
| T43221D | Poisoning by selective serotonin reuptake inhibitors, accidental (unintentional), subsequent encounter |
| T43222D | Poisoning by selective serotonin reuptake inhibitors, intentional self-harm, subsequent encounter |
| T43223D | Poisoning by selective serotonin reuptake inhibitors, assault, subsequent encounter |
| T43224D | Poisoning by selective serotonin reuptake inhibitors, undetermined, subsequent encounter |
| T43225D | Adverse effect of selective serotonin reuptake inhibitors, subsequent encounter |
| T43226A | Underdosing of selective serotonin reuptake inhibitors, initial encounter |
| T43226D | Underdosing of selective serotonin reuptake inhibitors, subsequent encounter |
| T43226S | Underdosing of selective serotonin reuptake inhibitors, sequela |
| T43291D | Poisoning by other antidepressants, accidental (unintentional), subsequent encounter |
| T43292D | Poisoning by other antidepressants, intentional self-harm, subsequent encounter |
| T43293D | Poisoning by other antidepressants, assault, subsequent encounter |
| T43294D | Poisoning by other antidepressants, undetermined, subsequent encounter |
| T43295D | Adverse effect of other antidepressants, subsequent encounter |
| T43296A | Underdosing of other antidepressants, initial encounter |
| T43296D | Underdosing of other antidepressants, subsequent encounter |
| T43296S | Underdosing of other antidepressants, sequela |
| T433X1D | Poisoning by phenothiazine antipsychotics and neuroleptics, accidental (unintentional), subsequent encounter |
| T433X2D | Poisoning by phenothiazine antipsychotics and neuroleptics, intentional self-harm, subsequent encounter |
| T433X3D | Poisoning by phenothiazine antipsychotics and neuroleptics, assault, subsequent encounter |
| T433X4D | Poisoning by phenothiazine antipsychotics and neuroleptics, undetermined, subsequent encounter |
| T433X5D | Adverse effect of phenothiazine antipsychotics and neuroleptics, subsequent encounter |
| T433X6A | Underdosing of phenothiazine antipsychotics and neuroleptics, initial encounter |
| T433X6D | Underdosing of phenothiazine antipsychotics and neuroleptics, subsequent encounter |
| T433X6S | Underdosing of phenothiazine antipsychotics and neuroleptics, sequela |
| T434X1D | Poisoning by butyrophenone and thiothixene neuroleptics, accidental (unintentional), subsequent encounter |
| T434X2D | Poisoning by butyrophenone and thiothixene neuroleptics, intentional self-harm, subsequent encounter |
| T434X3D | Poisoning by butyrophenone and thiothixene neuroleptics, assault, subsequent encounter |
| T434X4D | Poisoning by butyrophenone and thiothixene neuroleptics, undetermined, subsequent encounter |
| T434X5D | Adverse effect of butyrophenone and thiothixene neuroleptics, subsequent encounter |
| T434X6A | Underdosing of butyrophenone and thiothixene neuroleptics, initial encounter |
| T434X6D | Underdosing of butyrophenone and thiothixene neuroleptics, subsequent encounter |
| T434X6S | Underdosing of butyrophenone and thiothixene neuroleptics, sequela |
| T43501D | Poisoning by unspecified antipsychotics and neuroleptics, accidental (unintentional), subsequent encounter |
| T43502D | Poisoning by unspecified antipsychotics and neuroleptics, intentional self-harm, subsequent encounter |
| T43503D | Poisoning by unspecified antipsychotics and neuroleptics, assault, subsequent encounter |
| T43504D | Poisoning by unspecified antipsychotics and neuroleptics, undetermined, subsequent encounter |
| T43505D | Adverse effect of unspecified antipsychotics and neuroleptics, subsequent encounter |
| T43506A | Underdosing of unspecified antipsychotics and neuroleptics, initial encounter |
| T43506D | Underdosing of unspecified antipsychotics and neuroleptics, subsequent encounter |
| T43506S | Underdosing of unspecified antipsychotics and neuroleptics, sequela |
| T43591D | Poisoning by other antipsychotics and neuroleptics, accidental (unintentional), subsequent encounter |
| T43592D | Poisoning by other antipsychotics and neuroleptics, intentional self-harm, subsequent encounter |
| T43593D | Poisoning by other antipsychotics and neuroleptics, assault, subsequent encounter |
| T43594D | Poisoning by other antipsychotics and neuroleptics, undetermined, subsequent encounter |
| T43595D | Adverse effect of other antipsychotics and neuroleptics, subsequent encounter |
| T43596A | Underdosing of other antipsychotics and neuroleptics, initial encounter |
| T43596D | Underdosing of other antipsychotics and neuroleptics, subsequent encounter |
| T43596S | Underdosing of other antipsychotics and neuroleptics, sequela |
| T43601D | Poisoning by unspecified psychostimulants, accidental (unintentional), subsequent encounter |
| T43602D | Poisoning by unspecified psychostimulants, intentional self-harm, subsequent encounter |
| T43603D | Poisoning by unspecified psychostimulants, assault, subsequent encounter |
| T43604D | Poisoning by unspecified psychostimulants, undetermined, subsequent encounter |
| T43605D | Adverse effect of unspecified psychostimulants, subsequent encounter |
| T43606A | Underdosing of unspecified psychostimulants, initial encounter |
| T43606D | Underdosing of unspecified psychostimulants, subsequent encounter |
| T43606S | Underdosing of unspecified psychostimulants, sequela |
| T43611D | Poisoning by caffeine, accidental (unintentional), subsequent encounter |
| T43612D | Poisoning by caffeine, intentional self-harm, subsequent encounter |
| T43613D | Poisoning by caffeine, assault, subsequent encounter |
| T43614D | Poisoning by caffeine, undetermined, subsequent encounter |
| T43615D | Adverse effect of caffeine, subsequent encounter |
| T43616A | Underdosing of caffeine, initial encounter |
| T43616D | Underdosing of caffeine, subsequent encounter |
| T43616S | Underdosing of caffeine, sequela |
| T43621D | Poisoning by amphetamines, accidental (unintentional), subsequent encounter |
| T43622D | Poisoning by amphetamines, intentional self-harm, subsequent encounter |
| T43623D | Poisoning by amphetamines, assault, subsequent encounter |
| T43624D | Poisoning by amphetamines, undetermined, subsequent encounter |
| T43625D | Adverse effect of amphetamines, subsequent encounter |
| T43626A | Underdosing of amphetamines, initial encounter |
| T43626D | Underdosing of amphetamines, subsequent encounter |
| T43626S | Underdosing of amphetamines, sequela |
| T43631D | Poisoning by methylphenidate, accidental (unintentional), subsequent encounter |
| T43632D | Poisoning by methylphenidate, intentional self-harm, subsequent encounter |
| T43633D | Poisoning by methylphenidate, assault, subsequent encounter |
| T43634D | Poisoning by methylphenidate, undetermined, subsequent encounter |
| T43635D | Adverse effect of methylphenidate, subsequent encounter |
| T43636A | Underdosing of methylphenidate, initial encounter |
| T43636D | Underdosing of methylphenidate, subsequent encounter |
| T43636S | Underdosing of methylphenidate, sequela |
| T43691D | Poisoning by other psychostimulants, accidental (unintentional), subsequent encounter |
| T43692D | Poisoning by other psychostimulants, intentional self-harm, subsequent encounter |
| T43693D | Poisoning by other psychostimulants, assault, subsequent encounter |
| T43694D | Poisoning by other psychostimulants, undetermined, subsequent encounter |
| T43695D | Adverse effect of other psychostimulants, subsequent encounter |
| T43696A | Underdosing of other psychostimulants, initial encounter |
| T43696D | Underdosing of other psychostimulants, subsequent encounter |
| T43696S | Underdosing of other psychostimulants, sequela |
| T438X1D | Poisoning by other psychotropic drugs, accidental (unintentional), subsequent encounter |
| T438X2D | Poisoning by other psychotropic drugs, intentional self-harm, subsequent encounter |
| T438X3D | Poisoning by other psychotropic drugs, assault, subsequent encounter |
| T438X4D | Poisoning by other psychotropic drugs, undetermined, subsequent encounter |
| T438X5D | Adverse effect of other psychotropic drugs, subsequent encounter |
| T438X6A | Underdosing of other psychotropic drugs, initial encounter |
| T438X6D | Underdosing of other psychotropic drugs, subsequent encounter |
| T438X6S | Underdosing of other psychotropic drugs, sequela |
| T4391XD | Poisoning by unspecified psychotropic drug, accidental (unintentional), subsequent encounter |
| T4392XD | Poisoning by unspecified psychotropic drug, intentional self-harm, subsequent encounter |
| T4393XD | Poisoning by unspecified psychotropic drug, assault, subsequent encounter |
| T4394XD | Poisoning by unspecified psychotropic drug, undetermined, subsequent encounter |
| T4395XD | Adverse effect of unspecified psychotropic drug, subsequent encounter |
| T4396XA | Underdosing of unspecified psychotropic drug, initial encounter |
| T4396XD | Underdosing of unspecified psychotropic drug, subsequent encounter |
| T4396XS | Underdosing of unspecified psychotropic drug, sequela |
| T440X1D | Poisoning by anticholinesterase agents, accidental (unintentional), subsequent encounter |
| T440X2D | Poisoning by anticholinesterase agents, intentional self-harm, subsequent encounter |
| T440X3D | Poisoning by anticholinesterase agents, assault, subsequent encounter |
| T440X4D | Poisoning by anticholinesterase agents, undetermined, subsequent encounter |
| T440X5D | Adverse effect of anticholinesterase agents, subsequent encounter |
| T440X6A | Underdosing of anticholinesterase agents, initial encounter |
| T440X6D | Underdosing of anticholinesterase agents, subsequent encounter |
| T440X6S | Underdosing of anticholinesterase agents, sequela |
| T441X1D | Poisoning by other parasympathomimetics [cholinergics], accidental (unintentional), subsequent encounter |
| T441X2D | Poisoning by other parasympathomimetics [cholinergics], intentional self-harm, subsequent encounter |
| T441X3D | Poisoning by other parasympathomimetics [cholinergics], assault, subsequent encounter |
| T441X4D | Poisoning by other parasympathomimetics [cholinergics], undetermined, subsequent encounter |
| T441X5D | Adverse effect of other parasympathomimetics [cholinergics], subsequent encounter |
| T441X6A | Underdosing of other parasympathomimetics, initial encounter |
| T441X6D | Underdosing of other parasympathomimetics, subsequent encounter |
| T441X6S | Underdosing of other parasympathomimetics, sequela |
| T442X1D | Poisoning by ganglionic blocking drugs, accidental (unintentional), subsequent encounter |
| T442X2D | Poisoning by ganglionic blocking drugs, intentional self-harm, subsequent encounter |
| T442X3D | Poisoning by ganglionic blocking drugs, assault, subsequent encounter |
| T442X4D | Poisoning by ganglionic blocking drugs, undetermined, subsequent encounter |
| T442X5D | Adverse effect of ganglionic blocking drugs, subsequent encounter |
| T442X6A | Underdosing of ganglionic blocking drugs, initial encounter |
| T442X6D | Underdosing of ganglionic blocking drugs, subsequent encounter |
| T442X6S | Underdosing of ganglionic blocking drugs, sequela |
| T443X1D | Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, accidental (unintentional), subsequent encounter |
| T443X2D | Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, intentional self-harm, subsequent encounter |
| T443X3D | Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, assault, subsequent encounter |
| T443X4D | Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, undetermined, subsequent encounter |
| T443X5D | Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, subsequent encounter |
| T443X6A | Underdosing of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, initial encounter |
| T443X6D | Underdosing of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, subsequent encounter |
| T443X6S | Underdosing of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, sequela |
| T444X1D | Poisoning by predominantly alpha-adrenoreceptor agonists, accidental (unintentional), subsequent encounter |
| T444X2D | Poisoning by predominantly alpha-adrenoreceptor agonists, intentional self-harm, subsequent encounter |
| T444X3D | Poisoning by predominantly alpha-adrenoreceptor agonists, assault, subsequent encounter |
| T444X4D | Poisoning by predominantly alpha-adrenoreceptor agonists, undetermined, subsequent encounter |
| T444X5D | Adverse effect of predominantly alpha-adrenoreceptor agonists, subsequent encounter |
| T444X6A | Underdosing of predominantly alpha-adrenoreceptor agonists, initial encounter |
| T444X6D | Underdosing of predominantly alpha-adrenoreceptor agonists, subsequent encounter |
| T444X6S | Underdosing of predominantly alpha-adrenoreceptor agonists, sequela |
| T445X1D | Poisoning by predominantly beta-adrenoreceptor agonists, accidental (unintentional), subsequent encounter |
| T445X2D | Poisoning by predominantly beta-adrenoreceptor agonists, intentional self-harm, subsequent encounter |
| T445X3D | Poisoning by predominantly beta-adrenoreceptor agonists, assault, subsequent encounter |
| T445X4D | Poisoning by predominantly beta-adrenoreceptor agonists, undetermined, subsequent encounter |
| T445X5D | Adverse effect of predominantly beta-adrenoreceptor agonists, subsequent encounter |
| T445X6A | Underdosing of predominantly beta-adrenoreceptor agonists, initial encounter |
| T445X6D | Underdosing of predominantly beta-adrenoreceptor agonists, subsequent encounter |
| T445X6S | Underdosing of predominantly beta-adrenoreceptor agonists, sequela |
| T446X1D | Poisoning by alpha-adrenoreceptor antagonists, accidental (unintentional), subsequent encounter |
| T446X2D | Poisoning by alpha-adrenoreceptor antagonists, intentional self-harm, subsequent encounter |
| T446X3D | Poisoning by alpha-adrenoreceptor antagonists, assault, subsequent encounter |
| T446X4D | Poisoning by alpha-adrenoreceptor antagonists, undetermined, subsequent encounter |
| T446X5D | Adverse effect of alpha-adrenoreceptor antagonists, subsequent encounter |
| T446X6A | Underdosing of alpha-adrenoreceptor antagonists, initial encounter |
| T446X6D | Underdosing of alpha-adrenoreceptor antagonists, subsequent encounter |
| T446X6S | Underdosing of alpha-adrenoreceptor antagonists, sequela |
| T447X1D | Poisoning by beta-adrenoreceptor antagonists, accidental (unintentional), subsequent encounter |
| T447X2D | Poisoning by beta-adrenoreceptor antagonists, intentional self-harm, subsequent encounter |
| T447X3D | Poisoning by beta-adrenoreceptor antagonists, assault, subsequent encounter |
| T447X4D | Poisoning by beta-adrenoreceptor antagonists, undetermined, subsequent encounter |
| T447X5D | Adverse effect of beta-adrenoreceptor antagonists, subsequent encounter |
| T447X6A | Underdosing of beta-adrenoreceptor antagonists, initial encounter |
| T447X6D | Underdosing of beta-adrenoreceptor antagonists, subsequent encounter |
| T447X6S | Underdosing of beta-adrenoreceptor antagonists, sequela |
| T448X1D | Poisoning by centrally-acting and adrenergic-neuron-blocking agents, accidental (unintentional), subsequent encounter |
| T448X2D | Poisoning by centrally-acting and adrenergic-neuron-blocking agents, intentional self-harm, subsequent encounter |
| T448X3D | Poisoning by centrally-acting and adrenergic-neuron-blocking agents, assault, subsequent encounter |
| T448X4D | Poisoning by centrally-acting and adrenergic-neuron-blocking agents, undetermined, subsequent encounter |
| T448X5D | Adverse effect of centrally-acting and adrenergic-neuron-blocking agents, subsequent encounter |
| T448X6A | Underdosing of centrally-acting and adrenergic-neuron-blocking agents, initial encounter |
| T448X6D | Underdosing of centrally-acting and adrenergic-neuron-blocking agents, subsequent encounter |
| T448X6S | Underdosing of centrally-acting and adrenergic-neuron-blocking agents, sequela |
| T44901D | Poisoning by unspecified drugs primarily affecting the autonomic nervous system, accidental (unintentional), subsequent encounter |
| T44902D | Poisoning by unspecified drugs primarily affecting the autonomic nervous system, intentional self-harm, subsequent encounter |
| T44903D | Poisoning by unspecified drugs primarily affecting the autonomic nervous system, assault, subsequent encounter |
| T44904D | Poisoning by unspecified drugs primarily affecting the autonomic nervous system, undetermined, subsequent encounter |
| T44905D | Adverse effect of unspecified drugs primarily affecting the autonomic nervous system, subsequent encounter |
| T44906A | Underdosing of unspecified drugs primarily affecting the autonomic nervous system, initial encounter |
| T44906D | Underdosing of unspecified drugs primarily affecting the autonomic nervous system, subsequent encounter |
| T44906S | Underdosing of unspecified drugs primarily affecting the autonomic nervous system, sequela |
| T44991D | Poisoning by other drug primarily affecting the autonomic nervous system, accidental (unintentional), subsequent encounter |
| T44992D | Poisoning by other drug primarily affecting the autonomic nervous system, intentional self-harm, subsequent encounter |
| T44993D | Poisoning by other drug primarily affecting the autonomic nervous system, assault, subsequent encounter |
| T44994D | Poisoning by other drug primarily affecting the autonomic nervous system, undetermined, subsequent encounter |
| T44995D | Adverse effect of other drug primarily affecting the autonomic nervous system, subsequent encounter |
| T44996A | Underdosing of other drug primarily affecting the autonomic nervous system, initial encounter |
| T44996D | Underdosing of other drug primarily affecting the autonomic nervous system, subsequent encounter |
| T44996S | Underdosing of other drug primarily affecting the autonomic nervous system, sequela |
| T450X1D | Poisoning by antiallergic and antiemetic drugs, accidental (unintentional), subsequent encounter |
| T450X2D | Poisoning by antiallergic and antiemetic drugs, intentional self-harm, subsequent encounter |
| T450X3D | Poisoning by antiallergic and antiemetic drugs, assault, subsequent encounter |
| T450X4D | Poisoning by antiallergic and antiemetic drugs, undetermined, subsequent encounter |
| T450X5D | Adverse effect of antiallergic and antiemetic drugs, subsequent encounter |
| T450X6A | Underdosing of antiallergic and antiemetic drugs, initial encounter |
| T450X6D | Underdosing of antiallergic and antiemetic drugs, subsequent encounter |
| T450X6S | Underdosing of antiallergic and antiemetic drugs, sequela |
| T451X1D | Poisoning by antineoplastic and immunosuppressive drugs, accidental (unintentional), subsequent encounter |
| T451X2D | Poisoning by antineoplastic and immunosuppressive drugs, intentional self-harm, subsequent encounter |
| T451X3D | Poisoning by antineoplastic and immunosuppressive drugs, assault, subsequent encounter |
| T451X4D | Poisoning by antineoplastic and immunosuppressive drugs, undetermined, subsequent encounter |
| T451X5D | Adverse effect of antineoplastic and immunosuppressive drugs, subsequent encounter |
| T451X6A | Underdosing of antineoplastic and immunosuppressive drugs, initial encounter |
| T451X6D | Underdosing of antineoplastic and immunosuppressive drugs, subsequent encounter |
| T451X6S | Underdosing of antineoplastic and immunosuppressive drugs, sequela |
| T452X1D | Poisoning by vitamins, accidental (unintentional), subsequent encounter |
| T452X2D | Poisoning by vitamins, intentional self-harm, subsequent encounter |
| T452X3D | Poisoning by vitamins, assault, subsequent encounter |
| T452X4D | Poisoning by vitamins, undetermined, subsequent encounter |
| T452X5D | Adverse effect of vitamins, subsequent encounter |
| T452X6A | Underdosing of vitamins, initial encounter |
| T452X6D | Underdosing of vitamins, subsequent encounter |
| T452X6S | Underdosing of vitamins, sequela |
| T453X1D | Poisoning by enzymes, accidental (unintentional), subsequent encounter |
| T453X2D | Poisoning by enzymes, intentional self-harm, subsequent encounter |
| T453X3D | Poisoning by enzymes, assault, subsequent encounter |
| T453X4D | Poisoning by enzymes, undetermined, subsequent encounter |
| T453X5D | Adverse effect of enzymes, subsequent encounter |
| T453X6A | Underdosing of enzymes, initial encounter |
| T453X6D | Underdosing of enzymes, subsequent encounter |
| T453X6S | Underdosing of enzymes, sequela |
| T454X1D | Poisoning by iron and its compounds, accidental (unintentional), subsequent encounter |
| T454X2D | Poisoning by iron and its compounds, intentional self-harm, subsequent encounter |
| T454X3D | Poisoning by iron and its compounds, assault, subsequent encounter |
| T454X4D | Poisoning by iron and its compounds, undetermined, subsequent encounter |
| T454X5D | Adverse effect of iron and its compounds, subsequent encounter |
| T454X6A | Underdosing of iron and its compounds, initial encounter |
| T454X6D | Underdosing of iron and its compounds, subsequent encounter |
| T454X6S | Underdosing of iron and its compounds, sequela |
| T45511D | Poisoning by anticoagulants, accidental (unintentional), subsequent encounter |
| T45512D | Poisoning by anticoagulants, intentional self-harm, subsequent encounter |
| T45513D | Poisoning by anticoagulants, assault, subsequent encounter |
| T45514D | Poisoning by anticoagulants, undetermined, subsequent encounter |
| T45515D | Adverse effect of anticoagulants, subsequent encounter |
| T45516A | Underdosing of anticoagulants, initial encounter |
| T45516D | Underdosing of anticoagulants, subsequent encounter |
| T45516S | Underdosing of anticoagulants, sequela |
| T45521D | Poisoning by antithrombotic drugs, accidental (unintentional), subsequent encounter |
| T45522D | Poisoning by antithrombotic drugs, intentional self-harm, subsequent encounter |
| T45523D | Poisoning by antithrombotic drugs, assault, subsequent encounter |
| T45524D | Poisoning by antithrombotic drugs, undetermined, subsequent encounter |
| T45525D | Adverse effect of antithrombotic drugs, subsequent encounter |
| T45526A | Underdosing of antithrombotic drugs, initial encounter |
| T45526D | Underdosing of antithrombotic drugs, subsequent encounter |
| T45526S | Underdosing of antithrombotic drugs, sequela |
| T45601D | Poisoning by unspecified fibrinolysis-affecting drugs, accidental (unintentional), subsequent encounter |
| T45602D | Poisoning by unspecified fibrinolysis-affecting drugs, intentional self-harm, subsequent encounter |
| T45603D | Poisoning by unspecified fibrinolysis-affecting drugs, assault, subsequent encounter |
| T45604D | Poisoning by unspecified fibrinolysis-affecting drugs, undetermined, subsequent encounter |
| T45605D | Adverse effect of unspecified fibrinolysis-affecting drugs, subsequent encounter |
| T45606A | Underdosing of unspecified fibrinolysis-affecting drugs, initial encounter |
| T45606D | Underdosing of unspecified fibrinolysis-affecting drugs, subsequent encounter |
| T45606S | Underdosing of unspecified fibrinolysis-affecting drugs, sequela |
| T45611D | Poisoning by thrombolytic drug, accidental (unintentional), subsequent encounter |
| T45612D | Poisoning by thrombolytic drug, intentional self-harm, subsequent encounter |
| T45613D | Poisoning by thrombolytic drug, assault, subsequent encounter |
| T45614D | Poisoning by thrombolytic drug, undetermined, subsequent encounter |
| T45615D | Adverse effect of thrombolytic drugs, subsequent encounter |
| T45616A | Underdosing of thrombolytic drugs, initial encounter |
| T45616D | Underdosing of thrombolytic drugs, subsequent encounter |
| T45616S | Underdosing of thrombolytic drugs, sequela |
| T45621D | Poisoning by hemostatic drug, accidental (unintentional), subsequent encounter |
| T45622D | Poisoning by hemostatic drug, intentional self-harm, subsequent encounter |
| T45623D | Poisoning by hemostatic drug, assault, subsequent encounter |
| T45624D | Poisoning by hemostatic drug, undetermined, subsequent encounter |
| T45625D | Adverse effect of hemostatic drug, subsequent encounter |
| T45626A | Underdosing of hemostatic drugs, initial encounter |
| T45626D | Underdosing of hemostatic drugs, subsequent encounter |
| T45626S | Underdosing of hemostatic drugs, sequela |
| T45691D | Poisoning by other fibrinolysis-affecting drugs, accidental (unintentional), subsequent encounter |
| T45692D | Poisoning by other fibrinolysis-affecting drugs, intentional self-harm, subsequent encounter |
| T45693D | Poisoning by other fibrinolysis-affecting drugs, assault, subsequent encounter |
| T45694D | Poisoning by other fibrinolysis-affecting drugs, undetermined, subsequent encounter |
| T45695D | Adverse effect of other fibrinolysis-affecting drugs, subsequent encounter |
| T45696A | Underdosing of other fibrinolysis-affecting drugs, initial encounter |
| T45696D | Underdosing of other fibrinolysis-affecting drugs, subsequent encounter |
| T45696S | Underdosing of other fibrinolysis-affecting drugs, sequela |
| T457X1D | Poisoning by anticoagulant antagonists, vitamin K and other coagulants, accidental (unintentional), subsequent encounter |
| T457X2D | Poisoning by anticoagulant antagonists, vitamin K and other coagulants, intentional self-harm, subsequent encounter |
| T457X3D | Poisoning by anticoagulant antagonists, vitamin K and other coagulants, assault, subsequent encounter |
| T457X4D | Poisoning by anticoagulant antagonists, vitamin K and other coagulants, undetermined, subsequent encounter |
| T457X5D | Adverse effect of anticoagulant antagonists, vitamin K and other coagulants, subsequent encounter |
| T457X6A | Underdosing of anticoagulant antagonist, vitamin K and other coagulants, initial encounter |
| T457X6D | Underdosing of anticoagulant antagonist, vitamin K and other coagulants, subsequent encounter |
| T457X6S | Underdosing of anticoagulant antagonist, vitamin K and other coagulants, sequela |
| T458X1D | Poisoning by other primarily systemic and hematological agents, accidental (unintentional), subsequent encounter |
| T458X2D | Poisoning by other primarily systemic and hematological agents, intentional self-harm, subsequent encounter |
| T458X3D | Poisoning by other primarily systemic and hematological agents, assault, subsequent encounter |
| T458X4D | Poisoning by other primarily systemic and hematological agents, undetermined, subsequent encounter |
| T458X5D | Adverse effect of other primarily systemic and hematological agents, subsequent encounter |
| T458X6A | Underdosing of other primarily systemic and hematological agents, initial encounter |
| T458X6D | Underdosing of other primarily systemic and hematological agents, subsequent encounter |
| T458X6S | Underdosing of other primarily systemic and hematological agents, sequela |
| T4591XD | Poisoning by unspecified primarily systemic and hematological agent, accidental (unintentional), subsequent encounter |
| T4592XD | Poisoning by unspecified primarily systemic and hematological agent, intentional self-harm, subsequent encounter |
| T4593XD | Poisoning by unspecified primarily systemic and hematological agent, assault, subsequent encounter |
| T4594XD | Poisoning by unspecified primarily systemic and hematological agent, undetermined, subsequent encounter |
| T4595XD | Adverse effect of unspecified primarily systemic and hematological agent, subsequent encounter |
| T4596XA | Underdosing of unspecified primarily systemic and hematological agent, initial encounter |
| T4596XD | Underdosing of unspecified primarily systemic and hematological agent, subsequent encounter |
| T4596XS | Underdosing of unspecified primarily systemic and hematological agent, sequela |
| T460X1D | Poisoning by cardiac-stimulant glycosides and drugs of similar action, accidental (unintentional), subsequent encounter |
| T460X2D | Poisoning by cardiac-stimulant glycosides and drugs of similar action, intentional self-harm, subsequent encounter |
| T460X3D | Poisoning by cardiac-stimulant glycosides and drugs of similar action, assault, subsequent encounter |
| T460X4D | Poisoning by cardiac-stimulant glycosides and drugs of similar action, undetermined, subsequent encounter |
| T460X5D | Adverse effect of cardiac-stimulant glycosides and drugs of similar action, subsequent encounter |
| T460X6A | Underdosing of cardiac-stimulant glycosides and drugs of similar action, initial encounter |
| T460X6D | Underdosing of cardiac-stimulant glycosides and drugs of similar action, subsequent encounter |
| T460X6S | Underdosing of cardiac-stimulant glycosides and drugs of similar action, sequela |
| T461X1D | Poisoning by calcium-channel blockers, accidental (unintentional), subsequent encounter |
| T461X2D | Poisoning by calcium-channel blockers, intentional self-harm, subsequent encounter |
| T461X3D | Poisoning by calcium-channel blockers, assault, subsequent encounter |
| T461X4D | Poisoning by calcium-channel blockers, undetermined, subsequent encounter |
| T461X5D | Adverse effect of calcium-channel blockers, subsequent encounter |
| T461X6A | Underdosing of calcium-channel blockers, initial encounter |
| T461X6D | Underdosing of calcium-channel blockers, subsequent encounter |
| T461X6S | Underdosing of calcium-channel blockers, sequela |
| T462X1D | Poisoning by other antidysrhythmic drugs, accidental (unintentional), subsequent encounter |
| T462X2D | Poisoning by other antidysrhythmic drugs, intentional self-harm, subsequent encounter |
| T462X3D | Poisoning by other antidysrhythmic drugs, assault, subsequent encounter |
| T462X4D | Poisoning by other antidysrhythmic drugs, undetermined, subsequent encounter |
| T462X5D | Adverse effect of other antidysrhythmic drugs, subsequent encounter |
| T462X6A | Underdosing of other antidysrhythmic drugs, initial encounter |
| T462X6D | Underdosing of other antidysrhythmic drugs, subsequent encounter |
| T462X6S | Underdosing of other antidysrhythmic drugs, sequela |
| T463X1D | Poisoning by coronary vasodilators, accidental (unintentional), subsequent encounter |
| T463X2D | Poisoning by coronary vasodilators, intentional self-harm, subsequent encounter |
| T463X3D | Poisoning by coronary vasodilators, assault, subsequent encounter |
| T463X4D | Poisoning by coronary vasodilators, undetermined, subsequent encounter |
| T463X5D | Adverse effect of coronary vasodilators, subsequent encounter |
| T463X6A | Underdosing of coronary vasodilators, initial encounter |
| T463X6D | Underdosing of coronary vasodilators, subsequent encounter |
| T463X6S | Underdosing of coronary vasodilators, sequela |
| T464X1D | Poisoning by angiotensin-converting-enzyme inhibitors, accidental (unintentional), subsequent encounter |
| T464X2D | Poisoning by angiotensin-converting-enzyme inhibitors, intentional self-harm, subsequent encounter |
| T464X3D | Poisoning by angiotensin-converting-enzyme inhibitors, assault, subsequent encounter |
| T464X4D | Poisoning by angiotensin-converting-enzyme inhibitors, undetermined, subsequent encounter |
| T464X5D | Adverse effect of angiotensin-converting-enzyme inhibitors, subsequent encounter |
| T464X6A | Underdosing of angiotensin-converting-enzyme inhibitors, initial encounter |
| T464X6D | Underdosing of angiotensin-converting-enzyme inhibitors, subsequent encounter |
| T464X6S | Underdosing of angiotensin-converting-enzyme inhibitors, sequela |
| T465X1D | Poisoning by other antihypertensive drugs, accidental (unintentional), subsequent encounter |
| T465X2D | Poisoning by other antihypertensive drugs, intentional self-harm, subsequent encounter |
| T465X3D | Poisoning by other antihypertensive drugs, assault, subsequent encounter |
| T465X4D | Poisoning by other antihypertensive drugs, undetermined, subsequent encounter |
| T465X5D | Adverse effect of other antihypertensive drugs, subsequent encounter |
| T465X6A | Underdosing of other antihypertensive drugs, initial encounter |
| T465X6D | Underdosing of other antihypertensive drugs, subsequent encounter |
| T465X6S | Underdosing of other antihypertensive drugs, sequela |
| T466X1D | Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, accidental (unintentional), subsequent encounter |
| T466X2D | Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, intentional self-harm, subsequent encounter |
| T466X3D | Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, assault, subsequent encounter |
| T466X4D | Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, undetermined, subsequent encounter |
| T466X5D | Adverse effect of antihyperlipidemic and antiarteriosclerotic drugs, subsequent encounter |
| T466X6A | Underdosing of antihyperlipidemic and antiarteriosclerotic drugs, initial encounter |
| T466X6D | Underdosing of antihyperlipidemic and antiarteriosclerotic drugs, subsequent encounter |
| T466X6S | Underdosing of antihyperlipidemic and antiarteriosclerotic drugs, sequela |
| T467X1D | Poisoning by peripheral vasodilators, accidental (unintentional), subsequent encounter |
| T467X2D | Poisoning by peripheral vasodilators, intentional self-harm, subsequent encounter |
| T467X3D | Poisoning by peripheral vasodilators, assault, subsequent encounter |
| T467X4D | Poisoning by peripheral vasodilators, undetermined, subsequent encounter |
| T467X5D | Adverse effect of peripheral vasodilators, subsequent encounter |
| T467X6A | Underdosing of peripheral vasodilators, initial encounter |
| T467X6D | Underdosing of peripheral vasodilators, subsequent encounter |
| T467X6S | Underdosing of peripheral vasodilators, sequela |
| T468X1D | Poisoning by antivaricose drugs, including sclerosing agents, accidental (unintentional), subsequent encounter |
| T468X2D | Poisoning by antivaricose drugs, including sclerosing agents, intentional self-harm, subsequent encounter |
| T468X3D | Poisoning by antivaricose drugs, including sclerosing agents, assault, subsequent encounter |
| T468X4D | Poisoning by antivaricose drugs, including sclerosing agents, undetermined, subsequent encounter |
| T468X5D | Adverse effect of antivaricose drugs, including sclerosing agents, subsequent encounter |
| T468X6A | Underdosing of antivaricose drugs, including sclerosing agents, initial encounter |
| T468X6D | Underdosing of antivaricose drugs, including sclerosing agents, subsequent encounter |
| T468X6S | Underdosing of antivaricose drugs, including sclerosing agents, sequela |
| T46901D | Poisoning by unspecified agents primarily affecting the cardiovascular system, accidental (unintentional), subsequent encounter |
| T46902D | Poisoning by unspecified agents primarily affecting the cardiovascular system, intentional self-harm, subsequent encounter |
| T46903D | Poisoning by unspecified agents primarily affecting the cardiovascular system, assault, subsequent encounter |
| T46904D | Poisoning by unspecified agents primarily affecting the cardiovascular system, undetermined, subsequent encounter |
| T46905D | Adverse effect of unspecified agents primarily affecting the cardiovascular system, subsequent encounter |
| T46906A | Underdosing of unspecified agents primarily affecting the cardiovascular system, initial encounter |
| T46906D | Underdosing of unspecified agents primarily affecting the cardiovascular system, subsequent encounter |
| T46906S | Underdosing of unspecified agents primarily affecting the cardiovascular system, sequela |
![Previous Page [Alt-p]](bakpg.png){kind=small}
![Up a level [Alt-u]](uptop.png){kind=small}
![Next Page [Alt-n]](fwdpg.png){kind=small}